Cuiying C. Chen
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Serum N-glycan NA3Fb identified as a prognostic biomarker of poor outcome in HBV-related hepatocellular carcinoma.
Journal: Cancer cell international
Published: August 24, 2025
Serum N-glycomics for non-invasive detection of significant liver pathology across clinical phases of treatment-naïve chronic hepatitis B.
Journal: Journal of translational medicine
Published: August 03, 2025
Downregulation of Endo-Beta-N-Acetylglucosaminidase in Caenorhabditis elegans Improves Stress Adaptivity.
Journal: Cells, tissues, organs
Published: November 22, 2024
Early screening, diagnosis and recurrence monitoring of hepatocellular carcinoma in patients with chronic hepatitis B based on serum N-glycomics analysis: A cohort study.
Journal: Hepatology (Baltimore, Md.)
Published: October 07, 2024
A nanobody-enzyme fusion protein targeting PD-L1 and sialic acid exerts anti-tumor effects by C-type lectin pathway-mediated tumor associated macrophages repolarizing.
Journal: International journal of biological macromolecules
Published: September 12, 2024
A novel model based on serum N-glycan markers for evaluating stage of liver necroinflammation in treatment-naïve chronic hepatitis B patients.
Journal: Journal of medical virology
Published: May 04, 2024
Dose-response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B.
Dose-response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B.
Journal: Hepatology international
Published: April 09, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026